Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2015-03-18 Director's Dealing
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction made by a person performing managerial responsibilities ("Member of a managing body"). The content describes the exercise of stock options and the sale of shares by Dr. Ulf M. Schneider, which falls directly under the definition of insider trading or director transactions. This corresponds precisely to the 'Director's Dealing' category.
2015-03-18 English
Exane BNP Paribas - 17th Healthcare Conference
Investor Presentation Classification · 98% confidence The document text is a presentation titled 'A Leading Global Health Care Group' delivered at the 'Exane BNP Paribas 17th Health Care Conference, March 17, 2015'. It contains detailed financial results for FY14 and Q4/14, segment breakdowns, dividend development, and forward-looking statements/guidance for 2015 across various business units (Fresenius Kabi, Helios, Vamed). This structure—a presentation format with detailed financial tables and strategic updates given at an investor event—is characteristic of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K, nor is it a brief earnings release (ER). Since it is a detailed presentation given to investors, IP is the most appropriate classification.
2015-03-17 English
Declaration of Voting Results & Voting Rights Announcements 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details notifications received pursuant to section 21 para. 1 WpHG (German Securities Trading Act) regarding changes in the percentage of total voting rights held by BlackRock entities, crossing the 5% threshold. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or related voting rights changes.
2015-03-16 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains detailed information about a transaction performed by a person in a managerial role ('Member of a managing body'). It specifies the name of the person (Dr. Ulf M. Schneider), the type of transaction ('Exercise of stock options against cash settlement'), the date, price, and number of items traded. This directly matches the definition for Director's Dealing (DIRS). The presence of 'DGAP-DD' further confirms this is an insider transaction report.
2015-03-13 English
Report Publication Announcement 2015
Report Publication Announcement Classification · 100% confidence The document is a short announcement dated March 12, 2015, from Fresenius SE & Co. KGaA. It explicitly states that it is an 'Announcement according to articles 37v, 37w, 37x ff. WpHG' and its purpose is to disclose when various financial reports (Annual financial report, Quarterly financial report) will be made public (e.g., March 19, 2015, and May 08, 2015). Since the document itself is not the full financial report but rather an announcement about the *publication* of future reports, it fits the definition of a Report Publication Announcement (RPA). The document length (1986 chars) is short, supporting the 'MENU VS MEAL' rule.
2015-03-12 English
Declaration of Voting Results & Voting Rights Announcements 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details changes in the percentage of total voting rights held by BlackRock entities in Fresenius SE & Co. KGaA, referencing specific sections of the German Securities Trading Act (WpHG). This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes or related notifications about voting power changes.
2015-03-11 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.